Zeda’s acquisition of Orthopaedic Implant Company to expand options for Additive Manufacturing in medical sector
Zeda, Inc, Fremont, California, USA, has acquired the Orthopaedic Implant Company (OIC), based in Reno, Nevada. The move will enable Zeda to produce OIC’s implant designs in an effort to fortify and accelerate its goal of providing accessible, high-value trauma implants to patients on a worldwide scale.
“The acquisition of OIC represents a pivotal moment for Zeda,” stated Shri Shetty, CEO of Zeda. “Its leadership in value-based implants perfectly complements our Additive Manufacturing technologies that can deliver high-quality orthopaedic devices and implants that are accessible to all patients, regardless of country and socioeconomic status. Together, our strengths and expertise will raise the standard of care globally and equitably for the world’s entire population.”
Itai Nemovicher, CEO and co-founder of The Orthopaedic Implant Company, added, “We are proud to join forces with Zeda, a company that shares in our values and dedication to advancing access to critical orthopaedic care because it can and should be done. Under Zeda, OIC will reach new heights in providing cost-effective, high-quality orthopaedic solutions in the US and abroad.”
Under the terms of the acquisition by Zeda, OIC will operate worldwide as a Zeda Health company. The deal is intended to solidify Zeda’s position in the global orthopaedic industry as a company developing and using leading design and manufacturing technologies that push device design forward whilst improving affordability and access to care.
Read more about Zeda (formerly PrinterPrezz) in the Summer 2022 issue of Metal AM magazine:
